Live Breaking News & Updates on Company Or Unicycive

Stay updated with breaking news from Company or unicycive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Unicycive Announces First Quarter 2024 Financial Results And Provides Business Update

Unicycive Announces First Quarter 2024 Financial Results And Provides Business Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Shalabh-gupta , Kathleenm-hill , Lotus-international , Exchange-commission , Company-or-unicycive , National-kidney-foundation , Linkedin , European-renal-association , Unicycive-therapeutics-inc , University-of-minnesota

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Shalabh-gupta , Company-or-unicycive , Nasdaq , Unicycive-therapeutics-inc , Chief-executive-officer , Thursday-april ,

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

28.03.2024 - – Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose Portion of Clinical Trial Complete – LOS ALTOS, . ....

Sweden , Long-beach , California , United-states , Stockholm , Shalabh-gupta , Nasdaq , Linkedin , Development-rd-expenses , Exchange-commission , National-kidney-awareness-month , Drug-administration

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu ....

United-states , Stockholm , Sweden , United-kingdom , Satya-medicherla , Shalabh-gupta , Linkedin , Youtube , Exchange-commission , European-renal-association , Drug-administration , Nasdaq

Unicycive Therapeutics (UNCY) Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

Unicycive Therapeutics (UNCY) Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Satya-medicherla , Shalabh-gupta , Unicycive-therapeutics-inc , Intravenous-administration , Company-or-unicycive , Nasdaq , Unicycive-therapeutics , International-conference , Critical-care-nephrology , Chief-executive-officer , Acute-kidney-injury , Rat-model